Diasorin | DIA - Operating Expenses

Stock Price
64.50
Daily Change
0.72 1.13%
Monthly
-4.78%
Yearly
-32.77%
Q1 Forecast
62.02

Diasorin reported EUR224.05M in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Amplifon EUR 539.04M 16.22M Sep/2025
Avanos Medical USD 156.13M 2.7M Dec/2025
Brookdale Senior Living USD -6.73M 759.01M Sep/2025
Cencora USD 82.77B 3.09B Sep/2025
Diasorin EUR 224.05M 6.89M Sep/2025
Encompass Health USD 1.26B 27.3M Dec/2025
Enovis USD 573.32M 532.17M Dec/2025
GE HealthCare Technologies USD 4.41B 58M Sep/2025
OPKO Health USD 205.19M 11.6M Sep/2025
Pediatrix Medical Group USD 439.1M 20.23M Dec/2025
Veradigm USD 188M 61.08M Dec/2022
Zimmer Biomet Holdings USD 1.94B 277.8M Dec/2025